SLC6A1 Kids: Uniting Great Scientific Minds to Cure Genetic Epilepsy

We're on a mission to pioneer gene therapies addressing the root cause of SLC6A1 neurodevelopmental disorder. Join us at the forefront of scientific breakthroughs, working to advance understanding of this genetic condition and revolutionise treatment.

What Sets Us Apart:

• Gene Therapy Innovation: Actively developing cutting-edge gene therapies targeting the genetic mutations causing SLC6A1 neurodevelopmental disorder.
• Medical Empowerment: Raising awareness and knowledge amongst doctors to improve care for affected kids.

Join the Movement - Why It Matters:

• Real Impact: Explore the profound implications of SLC6A1 neurodevelopmental disorder and discover how our initiatives make a lasting impact.
• Medical Collaboration: Learn about our efforts to foster collaboration and knowledge-sharing within the medical community.

Scientific Breakthroughs - Advancing Gene Therapies:

• Cutting-Edge Research: Discover pioneering research into gene therapies, including Viral Vector Gene Addition, Antisense Oligonucleotides, and RNA Trans-Splicing.
• Clinical Progress: Follow our journey as we translate scientific discoveries into tangible, life-altering solutions.

Be Part of the Change:

• Support Our Mission: Contribute to the development of gene therapies, offering hope to affected children globally.
• Charitable Status Updates: Stay informed about our progress toward registered charity status in Australia.

Legal Framework and Structure:

• Legal Structure: SLC6A1 Kids Limited is a not-for-profit public company limited by guarantee in Australia, with pro bono support from PricewaterhouseCoopers.
• Constitution: Our operations adhere to Australian law, guided by our constitution, available for your review.

Join us on this transformative journey at SLC6A1 Kids, where we unite great scientific minds to turn scientific breakthroughs into hope for a brighter future.

SLC6A1 Kids

Org chart

Teams

Offices